Advertisement

Topics

ELRIG UK Announces 2017 Events

05:08 EST 28 Feb 2017 | Zyme Communications

Series of conferences and exhibitions encourages collaboration between thought leaders from industry and academia

York, UK, 28 February 2017: ELRIG UK, the not-for-profit organisation bringing together academic and biopharma industry experts and thought leaders, run by the drug discovery community for the drug discovery community, today announced its 2017 events programme.

The series of three events throughout the year has been designed to provide a platform for stimulation of discussions on a variety of topics of interest to researchers working in early drug discovery. All events feature a programme of world class science presentations from leaders in their fields, a trade show and exhibition, and poster competitions. Selected shows also have an innovation zone, aimed at showcasing the most exciting emerging life science companies. Delegate attendance at each of the events is free of charge.

Research & Innovation - Homerton College, Cambridge, 29-30 March 2017

Research & Innovation will bring together leading experts to discuss the challenges and opportunities for cells as models of disease to improve the success of drug discovery and develop new therapeutic agents.
http://elrig.org/portfolio/research-innovation-2017-elrigri17/

Advances in Cell-Based Screening - AstraZeneca, Gothenburg, Sweden, 10-11 May 2017

This interactive event will host leading scientists from academia and industry to discuss the latest developments in cell based screening in drug discovery. The meeting has been developed to cover key topics such as advanced cell models, applied omics, assays/methods exploring mode of action, phenotypic screening, target deconvolution, and much more.
http://elrig.org/portfolio/advances-in-cell-based-screening-2017-elrigcbs17/

Drug Discovery 2017 – ACC, Liverpool, 3-4 October 2017

ELRIG UK’s flagship event, now in its 11th year, bring together leading lights in drug discovery research across pharma, biotech, academia and the vendor community to explore innovative technologies and approaches that can be used to overcome drug development challenges.
http://elrig.org/portfolio/drug-discovery-2017-elrigdd17/

Dr Steve Rees, Chairman, ELRIG UK, said: "ELRIG UK is widely recognised as one of the UK’s most respected life science organisations, and we are committed to ensuring that our events provide highly relevant content and networking opportunities. In 2016 we saw record numbers of delegates attending our events, and our aim for 2017 is to build on that success, making our meetings accessible to an even broader audience.”

About ELRIG UK www.elrig.org

ELRIG UK is a UK-based not-for-profit organization that typically hosts 3 to 4 world-class meetings and conferences each year. ELRIG UK meetings are accessible to all delegates free-of-charge. To meet our open-access aims, we cover the cost of staging our events through the contributions of the exhibitors and sponsors. We also support an open policy of collaboration with other well-established and respected professional societies to add both breadth and depth to our offering.

With more than 7,000 life science professionals across the UK and Europe, our members include scientists, researchers, engineers, developers and business-people within academia, industry, government organizations and private institutes. 

ELRIG is located on the Sand Hutton Innovation Campus in the historic city of York, just two hours by train from London. The ELRIG UK organisation is run largely by volunteers from within our industry and is supported by a small professional administrative staff.

Media Contacts: Katie Odgaard Zyme Communications E: katie.odgaard@zymecommunications.com T: +44 (0)7787 502 947 Rhona McDonald Bennett / Liz Quinn Marketing Communications, ELRIG E: rhona.bennett@elrig.org / liz.quinn@elrig.org T: +44 (0)1904 405 177 NEXT ARTICLE

More From BioPortfolio on "ELRIG UK Announces 2017 Events"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...